4d4k
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | ''' | + | ==human PFKFB3 in complex with a pyrrolopyrimidone compound== |
- | + | <StructureSection load='4d4k' size='340' side='right' caption='[[4d4k]], [[Resolution|resolution]] 3.24Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[4d4k]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D4K OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4D4K FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BKE:7-(4-METHOXYPHENYL)-5-PHENYL-3,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-ONE'>BKE</scene>, <scene name='pdbligand=F6P:FRUCTOSE-6-PHOSPHATE'>F6P</scene>, <scene name='pdbligand=PHS:PHOSPHONIC+ACID'>PHS</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | |
- | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4d4j|4d4j]], [[4d4l|4d4l]], [[4d4m|4d4m]]</td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4d4k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4d4k OCA], [http://pdbe.org/4d4k PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4d4k RCSB], [http://www.ebi.ac.uk/pdbsum/4d4k PDBsum]</span></td></tr> | |
- | [[ | + | </table> |
- | [[ | + | == Function == |
- | [[ | + | [[http://www.uniprot.org/uniprot/F263_HUMAN F263_HUMAN]] Synthesis and degradation of fructose 2,6-bisphosphate. |
- | [[ | + | __TOC__ |
- | [ | + | </StructureSection> |
- | [ | + | [[Category: Bennett, N]] |
- | [ | + | |
- | + | ||
- | [[ | + | |
- | [[Category: | + | |
[[Category: Critchlow, S]] | [[Category: Critchlow, S]] | ||
+ | [[Category: Davies, G]] | ||
+ | [[Category: Debreczeni, J E]] | ||
+ | [[Category: Evans, N]] | ||
+ | [[Category: Holdgate, G]] | ||
+ | [[Category: Jones, N P]] | ||
+ | [[Category: Leach, L]] | ||
[[Category: Maman, S]] | [[Category: Maman, S]] | ||
- | [[Category: | + | [[Category: McLoughlin, S]] |
- | [[Category: | + | [[Category: Preston, M]] |
- | [[Category: | + | [[Category: Rigoreau, L]] |
+ | [[Category: Stgallay, S A]] | ||
+ | [[Category: Thomas, A]] | ||
+ | [[Category: Walker, G]] | ||
[[Category: Walsch, J]] | [[Category: Walsch, J]] | ||
- | [[Category: | + | [[Category: Ward, R A]] |
- | [[Category: | + | [[Category: Wheatley, E]] |
[[Category: Winter, J]] | [[Category: Winter, J]] | ||
- | [[Category: | + | [[Category: Oncology]] |
+ | [[Category: Sugar kinase]] | ||
+ | [[Category: Transferase]] | ||
+ | [[Category: Warburg effect]] |
Revision as of 17:08, 20 January 2016
human PFKFB3 in complex with a pyrrolopyrimidone compound
|
Categories: Bennett, N | Critchlow, S | Davies, G | Debreczeni, J E | Evans, N | Holdgate, G | Jones, N P | Leach, L | Maman, S | McLoughlin, S | Preston, M | Rigoreau, L | Stgallay, S A | Thomas, A | Walker, G | Walsch, J | Ward, R A | Wheatley, E | Winter, J | Oncology | Sugar kinase | Transferase | Warburg effect